Baxter Receives FDA Approval for PHOXILLUM Solution for Electrolyte Management During Continuous Renal Replacement Therapy
January 20, 2015 at 09:01 AM EST
Baxter International Inc. (NYSE: BAX) today announced the United States Food and Drug Administration (FDA) has approved PHOXILLUM Renal ...
